Adaptin Bio (APTN) Retained Earnings (2022 - 2026)
Adaptin Bio (APTN) posted Retained Earnings of $8.7 million for Q1 2026, up 193.22% sequentially from -$9.3 million in Q4 2025, and up 283.22% YoY from $2.3 million in Q1 2025.
Adaptin Bio (APTN) Retained Earnings (2022 - 2026) Analysis & Trends
Adaptin Bio has reported Retained Earnings for 5 years, with the latest figure at $8.7 million in Q1 2026.
- Quarterly Retained Earnings rose 283.22% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (up 283.22% YoY) and the FY2025 annual result came in at -$9.3 million, down 39155.95% from the prior year.
- Retained Earnings climbed to $8.7 million in Q1 2026 per APTN's latest filing, from -$9.3 million in the prior quarter.
- Over five years, Retained Earnings peaked at $8.7 million in Q1 2026 and troughed at -$9.3 million in Q4 2025.
- A 5-year average of -$1.7 million and a median of -$188369.0 in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings tumbled 39155.95% in 2025, then surged 283.22% in 2026.
- Over 5 years, Retained Earnings stood at -$27804.0 in 2022, then sank by 307.84% to -$113397.0 in 2023, then soared by 120.98% to $23791.0 in 2024, then sank by 39155.95% to -$9.3 million in 2025, then jumped by 193.22% to $8.7 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $8.7 million, -$9.3 million, and -$7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.64 Mn |
| Mar 31, 2026 | 8.66 Mn |
| Dec 31, 2025 | -9.29 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -6.25 Mn |
| Mar 31, 2025 | -4.73 Mn |
| Dec 31, 2024 | 23,791.00 |
| Sep 30, 2024 | -235,818.00 |
| Jun 30, 2024 | -206,167.00 |
| Mar 31, 2024 | -170,571.00 |
| Dec 31, 2023 | -113,397.00 |
| Sep 30, 2023 | -79,242.00 |
| Dec 31, 2022 | -27,804.00 |